You are here

Solutions

The role of civil society is very vital to strengthening good governance- State House Chief of Staff

THE PATRIOTIC VANGUARD   Aug. 20, 1015

FREETOWN, Sierra Leone --The Chief of Staff in the Office of the President Saidu Conton Sesay (pictured) has described the role of civil society as very vital in strengthening good governance in Sierra Leone.

He made this statement during a meeting with a consortium of civil society organizations Tuesday 18th August, 2015 at State House, Freetown. The purpose of the meeting was to work in collaboration with Office of the Chief of Staff in the implementation of the National Ebola Recovery Plan to enhance trust between citizens and government.

The Chief of Staff promised that his office is ready to work with civil society organizations in the implementation of the post-Ebola recovery plan not only to help establish public trust, but also keep informing each other about areas that need attention.

"The better society we have, the better the governance," Sesay said, adding that his office has posted two officers each to all districts - one facilitator and one analyst who will be engaging local councils to update them in detail. He expressed desire to meet with the consortium upon the return of officials assigned to the districts for better planning and understanding.

Country / Region Tags: 
General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Cheap Paper Test to Screen Patients for Ebola, Yellow Fever, Dengue

MEDGADGET                                                                                   Aug. 20, 2015

BOSTON --At the 250th National Meeting & Exposition of the American Chemical Society this week, researchers from MIT, Harvard Med School, and the FDA are showing off a new field test that can quickly screen people for Ebola, yellow fever, and dengue. While the researchers don’t claim their technique to be as accurate as PCR and ELISA, it is nevertheless an excellent tool in poor areas of the world where these diseases tend to thrive.

The test doesn’t require any water or electricity nor any complicated and expensive equipment. It works similar to pregnancy tests, providing a color readout that signals whether a disease is detected that is easily readable by just about anyone.

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

The Use of Intraosseous Fluid Resuscitation in a Pediatric Patient with Ebola Virus Disease

jem-journal.com - by Michael L. Paterson and Charles W. Callahan - August 14, 2015

 
Abstract
 
Background

Vomiting, diarrhea, and severe dehydration are common manifestations of Ebola virus disease (EVD), leading to its high mortality. Mortality is especially high in patients older than 45 years, younger than 5 years, and in pregnant women and their fetuses. The majority of patients with EVD are not able to tolerate the quantities of oral hydration solutions necessary to rehydrate properly. Although some have speculated that IV and intraosseous lines are not practical in the austere, resource-constrained settings of an Ebola treatment unit during an epidemic, it is necessary to provide parenteral fluids and electrolyte replacements to significantly decrease mortality. Due to the inability to spend long periods of time working in hot environments wearing personal protective equipment, it is necessary to maximize the use of rapidly obtainable and safe parenteral access.

Case Report
General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Using Public-Private Partnerships to Combat Ebola Globally

           

The Completed Containerized Biocontainment Systems Units at Dobbins Air Force Base, in Marietta, Georgia

blogs.state.gov - by Andrew O'Brien - August 13, 2015

In treating Ebola internationally, U.S. government personnel, doctors, nurses, aid workers, and other global health professionals are often put in direct contact with Ebola, and unfortunately some contract the virus themselves. Yet with limited resources, the U.S. Department of State needed more capacity to safely transport these Ebola patients to treatment facilities. Additionally, availability of medevac is important to getting doctors and epidemiologists from all over the world to volunteer to join the Ebola response.

By partnering with the Paul G. Allen Family Fund we were able to confront this challenge head on. Two containerized medevac biocontainment systems were funded by a $5 million grant by the Paul G. Allen Family Fund and the units were unveiled on August 11th at an event recognizing the partnership. MRIGlobal, a leading research institute, built the units, which are fully equipped to transport four patients, contain a broader array of dangerous pathogens, and fly aboard both military and civilian aircraft to multiple destinations in a single mission.

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Handwashing in W.African schools protects children, families from Ebola: UN

REUTERS by Monica MacSwan                                                                     Aug. 12, 2015

LONDON -- Handwashing and giving out soap in schools in Guinea, Liberia and Sierra Leone have helped to keep classrooms Ebola-free this year but schools need to remain vigilant after the summer holidays, the U.N. children's agency said on Wednesday.

UNICEF said there had been no reported cases of students or teachers contracting Ebola at a school this year in the three worst-hit countries in West Africa, where the virus has killed nearly 11,300 people since the outbreak began in late 2013.

In Liberia, where there have been as many as 4,800 deaths, two schools were decontaminated as a precaution after one student died in June and another became infected in July.

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Upscaling the "Farms of the Future"

             

The most promising soil and water management practices will be scaled up. Photo: N. Palmer (CIAT)

ccafs.cgiar.org - by Mathieu Ouedraogo, Sibiri Jean Ouedraogo, Sekou Toure, Maimouna Fane - August 11, 2015

A collaboration among regional research institutes and National Agricultural Research Systems establishes strong partnership for upscaling the “farms of the future” approach.

In West Africa, climate change brings new challenges to agriculture. Among other things, it is straining the livelihoods of the rural population, given their high dependence on the climate.

Because these challenges cannot be addressed by one research institution alone, the CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS) tackles the problem through an intervention approach based on a worldwide strategic collaboration between CGIAR and Future Earth.

Country / Region Tags: 
General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Proposed Ebola biobank would strengthen African science

NATURE by Erika Check Hayden                                                                             Aug. 10, 2015
As West Africa’s Ebola outbreak winds down, an effort is under way to make the best use of the tens of thousands of patient samples collected by public-health agencies fighting the epidemic.  Samples from the Ebola epidemic in West Africa are held by public-health agencies in the region and abroad. Daniel Berehulak/NYT/Redux/Eyevine

On 6–7 August, the World Health Organization (WHO) convened a meeting in Freetown, Sierra Leone, to discuss how to establish a biobank for up to 100,000 samples of blood, semen, urine and breast milk from confirmed and suspected Ebola patients, as well as swabs taken from the bodies of people who died from the virus. Held by health agencies in both West Africa and the West, the samples could be valuable in understanding how the current Ebola crisis evolved, preparing for future outbreaks and developing public-health research capacity in a region that depends on outside experts.

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Physicians: Global Vaccine Development Fund Could Save Billions

PHARMACEUTICAL PROCESSING by  Princeton University, Woodrow Wilson School of Public and International Affairs   Aug. 6, 2015

Ebola is a preventable disease, and yet a safe and effective vaccine has not been deployed. As with many vaccines, financial barriers persist: pharmaceutical companies see high costs with limited market potential, and government support is lacking. But there may be a solution to this vaccine crisis with the ability to save at-risk populations, according to a perspective piece written by physicians based at Princeton University, University of Pennsylvania and the Wellcome Trust.

The article, published in the New England Journal of Medicine, proposes the creation of a $2 billion global vaccine-development fund - supported by governments, foundations and pharmaceutical companies - that would carry promising vaccines through development to deployment. With initial support, the global vaccine fund could help make vaccines available for emergency use.

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Arktek Passive Vaccine Storage Device - P6

      

From watching the video in the link below, the Arktek vaccine cold storage device is also known as the P6 . . .
http://www.intellectualventures.com/inventions-patents/our-inventions/vaccine-cold-chain-device/

The P6 is not just a container, but an innovative high-tech device.  It is designed to keep vaccines at the appropriate temperatures for a month or more with repeat vaccine retrievals and no need for electricity (using just one initial batch of ice).  The device also has built-in communications and monitoring capability.  The P6 units are able to send live updates, including the units’ GPS positions viewable on interactive maps, the number of days since fresh ice had been added, temperature, and more.  Here are the details . . .
http://www.intellectualventureslab.com/invent/a-story-of-invention-the-passive-vaccine-storage-device

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

WHO: Trials Show New Ebola Vaccine is 'Highly Effective'

            

On March 23, 2015, Medecins Sans Frontieres (Doctors Without Borders) together with the World Health Organization started a clinical trial in Guinea to test the safety, efficacy and capacity substance to provoke an immune response of the anti-Ebola vaccine rVSV-EBOV.

cnn.com - by Laura Smith-Spark - July 31, 2015

(CNN) A newly developed vaccine against the deadly Ebola virus is "highly effective" and could help prevent its spread in the current and future outbreaks, the World Health Organization said Friday.

Trials of the single-dose VSV-EBOV vaccine began in March in Guinea -- one of three West African nations at the center of the outbreak -- and have shown such promise that this week it was decided to extend immediate vaccination to "all people at risk" after close contact with an infected person, a WHO news release said.

"This is an extremely promising development," said Dr. Margaret Chan, the body's director general.

(READ COMPLETE ARTICLE)

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Solutions
howdy folks